Potential of Receptor for Advanced Glycation End-Products (RAGE) as an Eligible Biomarker for Therapy Evaluation in Patients With Pulmonary Hypertension
Published: 2016 Received: February 09, 2016Released on J-STAGE: March 22, 2016Accepted: February 09, 2016
Advance online publication: March 11, 2016
Revised: -